RIPASUDIL News
RIPASUDIL currently has 0 news articles, with 12 predicted indications.
This page combines the AI-predicted indications for RIPASUDIL with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (12):
- glaucoma (99.0%)
- ocular hypertension (99.0%)
- hyperprolactinemia (disease) (99.9%)
- Axenfeld anomaly (99.9%)
- hydrophthalmos (99.8%)
- glaucoma 3, primary infantile, B (99.8%)
- familial hyperprolactinemia (99.8%)
- dense granule disease (99.8%)
- marcothrombocytopenia with mitral valve insufficiency (99.8%)
- hereditary thrombocytopenia with normal platelets (99.8%)
- transient neonatal thrombocytopenia (99.8%)
- thrombocytopenia (99.7%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.